Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-03-07
DOI
https://doi.org/10.1186/s12885-025-13794-w
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer

Yaoyue Zhang, Yue Shi, Yushan Jia, Zhikuan Wang et al.
BMC Cancer
Colorectal Cancer Treatments and Studies
article

Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer

Yaoyue Zhang, Yue Shi, Yushan Jia, Zhikuan Wang, Haiyan Si, Nan Zhang, Fangfang Liu, Quanli Han, Guanghai Dai, Ru Jia, Mengjiao Fan, Yue Ma, Yanrong Wang
article en

Abstract

No abstract available for this paper.
BMC CancerVol. 25(1)
Chinese PLA General Hospital (CN), PLA Academy of Military Science (CN), Chinese People's Liberation Army (CN)
Good health and well-being
Openalex Percentile: Top 94%
Colorectal Cancer Treatments and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.